Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor

Evaluating ALK tyrosine kinase inhibitor drugs for elderly patients with non-small cell lung cancer

Posted by on Sep 16, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of three different ALK tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). The authors concluded that these inhibitors were similarly effective, but elderly patients over age 65 were more likely to develop side effects. Some background NSCLC is...

Read More

Looking for patients with advanced non-small cell lung cancer to test a biological therapy.

Posted by on Sep 10, 2019 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness of pegilodecakin (AM0010) when it is used with pembrolizumab (Keytruda) to treat patients with advanced non-small cell lung cancer (NSCLC). The main outcome to be measured will be tumor responses to the treatment. This trial is recruiting in multiple locations around the United States. The...

Read More

Searching for patients with advanced non-small cell lung cancer to test a new combination therapy

Posted by on Aug 22, 2019 in Lung cancer | 0 comments

In a nutshell This phase 1b/2 trial will investigate the safety of cabozantinib (Cabometyx) with atezolizumab (Tecentriq) in patients with advanced solid tumors. The main outcomes will be the maximum tolerated dose (MTD) and overall response rate (ORR). The details Advanced cancers have limited treatment options. Surgery may not be possible. In...

Read More

Chemoradiotherapy versus radiation only – which is more effective in inoperable lung cancer?

Posted by on Aug 17, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of radiation therapy (RT) and chemoradiotherapy (CRT) in inoperable non-small cell lung cancer (NSCLC). They found that CRT was more effective than RT alone in these patients.  Some background Non-small cell lung cancer (NSCLC) is the most common form of lung cancer (LC)....

Read More

Looking for participants with metastatic non-small cell lung cancer to test a new immunotherapy

Posted by on Aug 14, 2019 in Lung cancer | 0 comments

In a nutshell This phase 1 trial is examining the effectiveness of personalized tumor antigens (PTA) in the treatment of different advanced tumors. The main outcomes to be measured will be side effects and disease control. This study is being conducted in Arizona, California, Louisiana and New Jersey, US. The details While the tumor cells are growing,...

Read More

Evaluating long-term outcomes for stereotactic ablative body radiotherapy for early-stage non-small cell lung cancer.

Posted by on Aug 13, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if using stereotactic ablative body radiotherapy (SABR) improves survival in patients with early-stage non-small cell lung cancer (NSCLC). The study found that this treatment resulted in good long-term survival and had few side effects. Some background Stereotactic ablative body radiotherapy (SABR) is...

Read More

Searching patients with relapsed or unresponsive cancer to test a new medication

Posted by on Jul 31, 2019 in Lung cancer | 0 comments

In a nutshell This phase 1b/2 trial will investigate the safety of RMC-4630 and cobimetinib (Cotellic) in relapsed or unresponsive solid tumors.  The main outcomes will be the number of side effects and the overall response rate. This trial is recruiting in a number of US states.  The details Relapsed/refractory (R/R) cancer is a term for...

Read More

Stereotactic body radiotherapy in patients with non-small cell lung cancer that has spread

Posted by on Jul 26, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out how well stereotactic body radiotherapy (SBRT) works in patients with non-small cell lung cancer (NSCLC) that has spread to one or two parts of the body (oligometastatic). The study found that SBRT is a good treatment option for these patients.  Some background Stereotactic body radiotherapy (SBRT)...

Read More

Searching for patients with previously treated non-small cell lung cancer to trial an immunotherapy combination

Posted by on Jun 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if treating recurrent non-small cell lung cancer with ramucirumab (Cyramza) and pembrolizumab (Keytruda) works better than standard care practices. The main outcome that will be measured is the overall survival rates.  This study will take place in the United States. The details There are a...

Read More